The Japanese journal of surgery

, Volume 19, Issue 3, pp 346–350 | Cite as

The protective effects of trimetazidine on normothermic ischemic myocardium in rats

  • Fazlur Rahman
  • Yoshihiro Toshima
  • Hiroyuki Kohno
  • Kazuhiko Kinoshita
  • Kouichi Tokunaga
Original Articles

Abstract

The protective effects of trimetazidine on postischemic cardiac function were studied using isolated working rat heart preparations in which global ischemia had been induced with normothermic cardioplegia. After 30 minutes of reperfusion, following a 25 minutes period of ischemia, the addition of 10−6 M or 10−5 M trimetazidine to the cardioplegic solution significantly increased the per cent recovery of the cardiac output: from 54.8±4.1 per cent in the control group to 81.0±3.2 per cent (p<0.01) and 79.6±4.0 per cent (p<0.01), respectively, although lower (10−7 M) or higher (10−4 M) doses of the drug failed to result in any change. 10−5 M trimetazidine also produced a significantly greater recovery of both the postischemic aortic flow: from 47.8±4.9 per cent to 72.2±3.8 per cent (p<0.01) and the coronary flow: from 80.6±2.9 per cent to 105.2±6.3 per cent (p<0.002). However, trimetazidine did not influence the recovery of either aortic pressure or heart rate. These results suggest that trimetazidine does give some protection to the heart during ischemia and reperfusion.

Key Words

trimetazidine myocardial protection ischemia reperfusion cardioplegia 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Nagata M, Imamura I, Fugono R, Sugimoto J. The actions of trimetazidine on isolated guinea-pig atria. Jpn J Pharmacol 1971; 21: 337–343.PubMedGoogle Scholar
  2. 2.
    Toda N, Usui H, Osumi S, Kanda M, Kitao K. Influence of trimetazidine, an antianginal drug, on isolated dog arteries and veins. Arch Int Pharmacodyn Ther 1982; 260: 230–243.PubMedGoogle Scholar
  3. 3.
    Maridonneau-Parini I, Harpey C. Effect of trimetazidine on membrane damage induced by oxygen free radicals in human red cells. Br J Clin Pharmacol 1985; 20: 148–151.PubMedGoogle Scholar
  4. 4.
    Maridonneau-Parini I, Harpey C, Finardi G. Effects of vastarel 20 mg on membrane changes induced by oxygenated free radicals in human erythrocytes. Gaz Med 1984; 91: 63–67.Google Scholar
  5. 5.
    Yasunaga K, Kanzaki M, Kimura M, Fujii T, Sato T. Inhibitory effects of trimetazidine hydrochloride on the platelet aggregation. Jpn Arch Int Med 1980; 21: 1–8. (in Japanese)Google Scholar
  6. 6.
    Gauduel Y, Duvelleroy MA. Role of oxygen radicals in cardiac injury due to reoxygenation. J Mol Cell Cardiol 1984; 16: 549–570.Google Scholar
  7. 7.
    Meerson FZ, Kagan VE, Kazlov YP, Belkina LM, Arkhipenko YV. The role of lipid peroxidation in pathogenesis of ischemic damage and the antioxidant protection of the heart. Basic Res Cardiol 1982; 7: 465–485.CrossRefGoogle Scholar
  8. 8.
    McCord JM. Oxygen-derived free radicals in post-ischemic tissue injury. New Engl J Med 1985; 312: 159–163.PubMedCrossRefGoogle Scholar
  9. 9.
    Hess ML, Manson NH. Molecular oxygen: Friend and foe. The role of the oxygen free radical system in the calcium paradox, the oxygen paradox and ischemia/reperfusion injury. J Mol Cell Cardiol 1984; 16: 969–985.PubMedGoogle Scholar
  10. 10.
    Chambers DE, Parks DA, Patterson G, Roy R, McCord JM, Yoshida S, Parmley LF, Downey JM. Xanthine oxidase as a source of free radical damage in myocardial ischemia. J Mol Cell Cardiol 1985; 17: 145–152.PubMedGoogle Scholar
  11. 11.
    Nagata M, Imamura I, Sugimoto J. Anti-nicotinic action of vastarel on guinea-pig atria. Jpn J Pharmacol 1969; 19: 628.PubMedGoogle Scholar

Copyright information

© The Japan Surgical Society 1989

Authors and Affiliations

  • Fazlur Rahman
    • 1
  • Yoshihiro Toshima
    • 1
  • Hiroyuki Kohno
    • 1
  • Kazuhiko Kinoshita
    • 1
  • Kouichi Tokunaga
    • 1
  1. 1.The Department of Cardiovascular SurgeryKyushu University School of MedicineFukuokaJapan

Personalised recommendations